Zhongnan Medical Journal Press

Home Results

A total of 5 result was found. Results that relate to Sintilimab

A case of toxic epidermal necrolysis caused by sorafenib and sintilimab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):224-229.
7075 times 1649 times

DENG Lin REN Chao SUN Tao LI Xi GUO Shun ZHOU Ang

Sorafenib Sintilimab Toxic epidermal necrolysis Adverse drug reactions
Details
Evaluation of efficacy and safety of Sintilimab+Bevacizumab combined with PP regime in patients with advanced non-squamous non-small cell lung cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(1):93-99.
5245 times 1365 times

SHEN Junjie JIN Jianwei RUAN Zekun ZHANG Weiping

Advanced non-squamous non-small lung cell cancer Sintilimab Bevacizumab Efficay Safety
Details
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):485-490.
9254 times 1905 times

SU Zhan CHE Jinhui PEI Ruifeng

Advanced hepatocellular carcinoma Sintilimab Bevacizumab Clinical efficacy Safety Overall survival Progression-free survival
Details
A case of intestinal hemorrhage caused by immune enteritis due to sintilimab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):818-823.
9577 times 1886 times

MENG Baowei WU Caizhi MA Yongming CHANG Ruitong YANG Xiaogang TIAN Huashan WU Zhiqiang YIN Rui ZHU Zijiang

Sintilimab Non-small cell lung cancer Immune enteritis Intestinal bleeding Adverse drug reactions
Details
Efficacy and safety of SOX chemotherapy combined with Sintilimab immunotherapy in treatment of patients with advanced gastric cancer

Published on New Medicine 2026,36(1):15-21.
991 times 156 times

ZHAO Wan YAN Jing GUO Yaping FU Qinghua LUO Yan ZHANG Xiaojuan CHEN Yang YANG Yi TANG Xinyu

Gastric cancer Sintilimab SOX regimen Chemotherapy response Prognosis
Details